Letâ€™s have a look at Clinical Research
On the grand occasion of 3rd anniversary Journal of Clinical Research expresses gratitude to all its elite panel of editorial board members for their continuous efforts, support and encouragement throughout the publication journey of the journal, right from its inception in the year 2010 and congratulates them for making the journal achieve its goals and becoming successful as one of the leading and well-recognized broadcaster of scientific outcomes and perspectives from Clinical Research globally.
The journal is extremely privileged to have Dr. Timothy Low as its Editor-in-Chief, leading the board of academic editorial panel. The journal expresses appreciation for professional execution of his responsibilities which include spearheading the overall editorial activity of the journal and gaining commercial acclaim in open access publishing in addition to coining the special issue themes and guiding the compilation and production of special issues and titles as per the contemporary information demands.
Dr. Timothy Low has more than 30 years in the healthcare space, Dr Timothy Low is an established name in the industry. He is the Board Member of Farrer Park Hospital. In the last 2 consecutive years, he was awarded the “50 Most Talented Healthcare Leaders of Asia” award as well as “Best CEO of the Year” at the Asia Healthcare Excellence Award conferred by CMO Asia in 2016 and 2017 respectively. He has research interest in Clinical Research and Hospital Management.
We are honor to have editorials board members for our journal and some of them are Prof. Peifeng Li is currently working as Professor and dean of Medical Researcher at Max-Delbruck Center for Molecular Medicine in Germany for ten years Qingdao University, China. He has served as a reviewer for many international foundations. Dr. Li has published over 80 articles in journals such as Molecular Cell, EMBO Journal, Nature Medicine, Nature Communication, Circulation, Circulation Research, PNAS. Based on his academic contributions, he has been honored with several prestigious accolades awards. His current research focuses include cardiovascular apoptosis and necrosis, non-coding RNA in heart diseases, and cardiac regeneration. He has authored several International publications which were widely and frequently cited all across the world. He is active participant in several International conferences on Molecular Cell.
Omics Publishing is proud to have onboard Giuseppe Murdaca to lead the academic and managerial team of the journal. His interest and admiration regarding Omics founding principles as an open access publication brand are highly appreciated and we hope to grow as a. Giuseppe Murdaca consistently brings in fresh insights guided by his passion for Immunodeficiency, oriented research and he is a great asset to advance our open access model of publishing in the highly sought after field of Neuro-endocrino-immunology. Giuseppe Murdaca academic and research experience is highly valuable and relevant in guiding the contemporary researchers to advance scientific enquiry and explorations as well as in conducting editorship to make their research globally discoverable; helping the medical education sector avail the digital resources and helping the clinical professionals in keeping themselves updated with latest observations.
Journal of Clinical Research
For more queries WhatsApp me on +44-7482-87-62